IGF1 Treatment Improves Cardiac Remodeling after Infarction by Targeting Myeloid Cells.


Journal

Molecular therapy : the journal of the American Society of Gene Therapy
ISSN: 1525-0024
Titre abrégé: Mol Ther
Pays: United States
ID NLM: 100890581

Informations de publication

Date de publication:
02 01 2019
Historique:
received: 24 07 2018
revised: 25 10 2018
accepted: 26 10 2018
pubmed: 12 12 2018
medline: 18 12 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Insulin-like growth factor 1 (IGF1) is an anabolic hormone that controls the growth and metabolism of many cell types. However, IGF1 also mediates cardio-protective effects after acute myocardial infarction (AMI), but the underlying mechanisms and cellular targets are not fully understood. Here we demonstrate that short-term IGF1 treatment for 3 days after AMI improved cardiac function after 1 and 4 weeks. Regional wall motion was improved in ischemic segments, scar size was reduced, and capillary density increased in the infarcted area and the border zone. Unexpectedly, inducible inactivation of the IGF1 receptor (IGF1R) in cardiomyocytes did not attenuate the protective effect of IGF1. Sequential cardiac transcriptomic analysis indicated an altered myeloid cell response in the acute phase after AMI, and, notably, myeloid-cell Igf1r

Identifiants

pubmed: 30528085
pii: S1525-0016(18)30527-6
doi: 10.1016/j.ymthe.2018.10.020
pmc: PMC6319026
pii:
doi:

Substances chimiques

Insulin-Like Growth Factor I 67763-96-6
Receptor, IGF Type 1 EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-58

Informations de copyright

Copyright © 2018 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Références

Circ Res. 2007 Jun 22;100(12):1732-40
pubmed: 17525368
Mediators Inflamm. 2015;2015:484357
pubmed: 26491228
Circ Res. 2018 Jun 8;122(12):1661-1674
pubmed: 29545365
J Exp Med. 2007 Nov 26;204(12):3037-47
pubmed: 18025128
Circ Res. 2016 Jun 24;119(1):91-112
pubmed: 27340270
Cardiovasc Res. 2016 Aug 1;111(3):184-93
pubmed: 27013635
Annu Rev Physiol. 2017 Feb 10;79:541-566
pubmed: 27813830
J Transl Med. 2016 Jan 06;14:3
pubmed: 26733412
Eur J Histochem. 2014 Dec 17;58(4):2448
pubmed: 25578975
J Leukoc Biol. 2018 May;103(5):829-838
pubmed: 29462505
Cardiovasc Res. 2016 May 1;110(1):51-61
pubmed: 26825554
Ultrasound Med Biol. 2018 Jul;44(7):1544-1555
pubmed: 29706407
Mediators Inflamm. 2015;2015:816460
pubmed: 26089604
Circ Cardiovasc Interv. 2011 Aug;4(4):327-35
pubmed: 21712526
Eur Heart J. 2014 Apr;35(15):989-98
pubmed: 24026778
Microcirculation. 2017 Jan;24(1):
pubmed: 27542099
Am J Physiol Endocrinol Metab. 2012 Jul 15;303(2):E213-22
pubmed: 22589390
J Mol Cell Cardiol. 2013 Sep;62:24-35
pubmed: 23644221
PLoS One. 2015 Dec 23;10(12):e0145342
pubmed: 26699615
Nat Med. 2015 Feb;21(2):140-9
pubmed: 25581518
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Heart. 2001 Dec;86(6):693-700
pubmed: 11711471
Circ Res. 2016 Sep 16;119(7):853-64
pubmed: 27444755
Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):277-82
pubmed: 9484994
Circ Res. 2016 Jan 8;118(1):95-107
pubmed: 26837742
Circulation. 2017 Nov 7;136(19):1809-1823
pubmed: 28931551
Endocrinology. 2001 May;142(5):1685-8
pubmed: 11316729
J Immunol. 2006 Nov 15;177(10):7303-11
pubmed: 17082649
EMBO J. 2008 Aug 6;27(15):2091-101
pubmed: 18650937
J Mol Cell Cardiol. 2018 Jun;119:51-63
pubmed: 29680681
Circulation. 2012 Apr 10;125(14):1765-73, S1-7
pubmed: 22403243
J Cell Mol Med. 2009 Sep;13(9B):3485-96
pubmed: 19228260
Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):8031-5
pubmed: 7644533
Immunity. 2014 Feb 20;40(2):274-88
pubmed: 24530056
Transgenic Res. 1999 Aug;8(4):265-77
pubmed: 10621974
Am J Cardiol. 2009 Feb 1;103(3):333-7
pubmed: 19166685
J Clin Endocrinol Metab. 2015 May;100(5):1879-86
pubmed: 25699636
Eur Heart J. 2017 Jan 14;38(3):187-197
pubmed: 28158426
Atherosclerosis. 2011 Oct;218(2):464-9
pubmed: 21708381
Circulation. 2002 Aug 20;106(8):939-44
pubmed: 12186797
Circ Res. 2011 Apr 15;108(8):908-16
pubmed: 21372284

Auteurs

Andre Heinen (A)

Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Rianne Nederlof (R)

Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Priyadarshini Panjwani (P)

Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

André Spychala (A)

Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Tengis Tschaidse (T)

Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Heiko Reffelt (H)

Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Johannes Boy (J)

Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Annika Raupach (A)

Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Stefanie Gödecke (S)

Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Patrick Petzsch (P)

Biologisch-Medizinisches Forschungszentrum (BMFZ), Genomics and Transcriptomics Labor, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Karl Köhrer (K)

Biologisch-Medizinisches Forschungszentrum (BMFZ), Genomics and Transcriptomics Labor, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Maria Grandoch (M)

Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Anne Petz (A)

Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Jens W Fischer (JW)

Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Christina Alter (C)

Institut für Molekulare Kardiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Jelena Vasilevska (J)

Institut für Molekulare Medizin II, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Philipp Lang (P)

Institut für Molekulare Medizin II, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany.

Axel Gödecke (A)

Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, 40225 Düsseldorf, Germany. Electronic address: axel.goedecke@uni-duesseldorf.de.

Articles similaires

Humans Male Female Anemia Myocardial Infarction
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH